Lonza and ABL Bio collaborate on development and manufacture of new bispecific antibody product
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
The collaboration between both the ministries will play an important role in enhancing the skill and service sector related to Ayurveda
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
Honan will lead the company in identifying and executing acquisitions that complement Emmes’ existing strong federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
Through the collaboration, Lonza will gain access to Singzyme’s enzymatic conjugation platform enabling the site-specific binding of payloads with peptidic linkers to proteins of interest
Subscribe To Our Newsletter & Stay Updated